Perioperative β blockade: the debate continues

The Lancet

Volumn 373, Issue 9664, 2009, Pages 627-

  Angeli, Fabio ^a   Verdecchia, Paolo ^a   Del Pinto, Maurizio ^a   Cavallini, Claudio ^a   Reboldi, Gianpaolo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIOTONIC AGENT;

BRADYCARDIA; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; HEART INFARCTION; HUMAN; HYPOTENSION; LETTER; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; STROKE; SURGICAL MORTALITY; SURGICAL RISK; CLASSIFICATION; MORTALITY; NOTE; PEROPERATIVE COMPLICATION; RISK ASSESSMENT; SURGERY; CHEMICALLY INDUCED DISORDER;

ADRENERGIC BETA-ANTAGONISTS; HUMANS; INTRAOPERATIVE COMPLICATIONS; MORTALITY; PERIOPERATIVE CARE; RISK ASSESSMENT; SURGICAL PROCEDURES, OPERATIVE; CARDIOTONIC AGENTS; STROKE;

EID: 60249100355     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)60388-3     Document Type: Letter

References (4)

1. Bangalore S., Wetterslev J., Pranesh S., Sawhney S., Gluud C., and Messerli F.H. Perioperative β blockers in patients having non-cardiac surgery: a meta-analysis. Lancet 372 (2008) 1962-1976
2. Fleisher L.A., Beckman J.A., Brown K.A., et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 50 (2007) 1707-1732
3. Thompson S.G., and Higgins J.P. How should meta-regression analyses be undertaken and interpreted?. Stat Med 21 (2002) 1559-1573
4. Higgins J.P.T., and Thompson S.G. Controlling the risk of spurious findings from meta-regression. Stat Med 23 (2004) 1663-1682